Apr 16, 2018 12:01 pm UTC| Business
SAN DIEGO, April 16, 2018 -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced a podium presentation on the structure and...
Kimberly Warnica Joins Alta Mesa Senior Leadership Team as General Counsel
Apr 16, 2018 12:01 pm UTC| Business
HOUSTON, April 16, 2018 -- Alta Mesa Resources, Inc. (NASDAQ:AMR) (“Alta Mesa” or the “Company”) today announced that Kimberly Warnica has joined the Company as Vice President, General Counsel, Chief Compliance Officer,...
Apr 16, 2018 12:01 pm UTC| Business
MOORESTOWN, N.J., April 16, 2018 -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ:TRHC), a healthcare technology company that develops and employs medication risk mitigation software solutions and tools to optimize...
Apr 16, 2018 12:01 pm UTC| Business
NEW YORK, April 16, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NetApp, Inc....
Apr 16, 2018 12:01 pm UTC| Business
Denver, CO, April 16, 2018 -- Medicine Man Technologies Inc. (OTCQB: MDCL) (“Medicine Man Technologies” or “Company”), one of the United States' leading cannabis branding and consulting companies today...
Apr 16, 2018 12:01 pm UTC| Business
CINCINNATI, OH LOS ANGELES, CA , April 16, 2018 -- Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F2), (the "Company" or “Callitas”) an integrated clinical-stage pharmaceutical development and OTC consumer goods...
XBiotech Announces Upcoming Phase 2 Clinical Studies in Dermatology
Apr 16, 2018 12:01 pm UTC| Business
AUSTIN, Texas, April 16, 2018 -- XBiotech Inc. (NASDAQ:XBIT) announced today that it would evaluate a new subcutaneous formulation of the Company’s True Human™ monoclonal antibody, MABp1, in two separate Phase 2, open...